MAPK3 and cholangiocarcinoma: Although these findings underscore the central role of the ERK1/2 pathway in CCA tumorigenesis, most of the scientific evidence is focused on iCCA, where the aberrant activation of ERK1/2 signaling has been reported by several external and internal stimuli.